Plant investigation: although it was stated by the user facility that the complaint sample is available to be returned to the manufacturer, no sample has been received for evaluation at this time.A production records review was performed on the reported lot.An investigation of the device manufacturing records was conducted by the manufacturer.The lot had two approved temporary deviation notices (dn) that were unrelated to the reported complaint event.There was no indication of product non-acceptance or deviation during the manufacturing process which could be associated with the reported event.The review included a check of non-conformances, rework, labeling, process controls, and any other occurrence in production potentially related to the complaint.The lot passed all release criteria.The reported complaint was not confirmed as the complaint device was not returned for manufacturer evaluation.As such, a definitive conclusion regarding the complaint incident cannot be reached without a physical examination of the complaint device.
|
A user facility patient care technician (pct) reported that an internal dialyzer blood leak occurred immediately after the initiation of a patient¿s hemodialysis (hd) treatment.The machine alarmed for blood leak, but blood was not visually observed.However, blood test strips were used at the drain line and confirmed the presences of blood in the dialysate.No dialyzer defect or damage was visible.The patient¿s estimated blood loss (ebl) was noted as being approximately 200ml as the patient¿s blood was not returned in the circuit.No patient adverse effects were experienced and no medical intervention was required as a result of this event.The patient completed treatment with a new set-up of supplies on the same machine.The complaint device was reported to be available to be returned to the manufacturer for evaluation.
|